A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Detalles Bibliográficos
Autor principal:	Islam, Saidul
Otros Autores:	Sharmin, Shahana
Formato:	Tesis
Lenguaje:	English
Publicado:	Brac University 2022
Materias:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Acceso en línea:	http://hdl.handle.net/10361/17308

Ejemplares similares

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
por: Karim, Azrin
Publicado: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Flora, Sanzida Alam
Publicado: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
por: Meem, Manila
Publicado: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
por: Alam, Tahera
Publicado: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
por: Jahan, Nusrat
Publicado: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
por: Ahmed, Nafisa
Publicado: (2023)

Immunotherapy in the Management of Lung Cancer
por: Tasnim, Humayra
Publicado: (2022)

A review on triple-negative breast cancer and its potential treatment
por: Niasa, Jannatul Ferdous
Publicado: (2023)

Stem cells as therapeutic carrier in cancer treatment
por: Anika, Mysha Yeasmin
Publicado: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
por: Hasan, Amit
Publicado: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
por: Chakraborty, Anuradha
Publicado: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
por: Khan, Muidul Hasan
Publicado: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
por: Roy, Hredita
Publicado: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
por: Emon, Kamrul Hasan
Publicado: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
por: Mirza, Maisa Tasnim
Publicado: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
por: Khan, Rezia Nowrin
Publicado: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
por: Nuha, Nabiha Tahsin
Publicado: (2024)

Role of statins as antagonists of SPARC in gastric cancer
por: Shahmat, Rad
Publicado: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
por: Sorno, Rubina Haque
Publicado: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
por: Ratu, Tabassum
Publicado: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
por: Choki, Kinley
Publicado: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
por: Razna, Amrin Islam
Publicado: (2019)

A comprehensive review on drug repurposing in cancer treatment
por: Sarkar, Onusree
Publicado: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
por: Mahaleka, Aarshi
Publicado: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
por: Shaikat, Mahdi Mubin
Publicado: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
por: Hasan, Sakib
Publicado: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
por: Nawar, Anika
Publicado: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
por: Deeba, Maliha Tasnim
Publicado: (2018)

Targeting BRAFV600E in the treatment of CRC
por: Roja, Mashwiyat Samrin
Publicado: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
por: Alam, Kazi Tasnuva
Publicado: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
por: Rahman, Sanjida
Publicado: (2024)

Biosimilar in lymphoma treatment
por: Tanisha, Mehrin Haque
Publicado: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
por: Khondokar, Faiza
Publicado: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
por: Islam, Nahidul
Publicado: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
por: Beruni, Sajid Mahmud Al
Publicado: (2022)

Oncogenes: new targets in cancer treatment
por: Chowdhury, Waseka Shams
Publicado: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
por: Muntaha, Habibatul
Publicado: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
por: Haque, Mushfiqul
Publicado: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Karim, Samia Binte
Publicado: (2024)